Flagship-backed startup raises $85M for 'gene-tuning' drugs
July 29, 2020 at 14:49 PM EDT
Omega Therapeutics is developing drugs using a scientific approach that's seeing renewed interest.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|